Overexpression of UHRF1 occurs in many types of cancer, and aberrantly expressed UHRF1 causes cancer cell activation through hyper-methylation of tumor-suppressor genes such as BRCA1, CDKN2A, p73, and RASSF1 [32]. Here, CDKN2A is linked to cancer.